US FDA authorises Pfizer COVID-19 vaccine booster for children ages 12 to 15
The US Food and Drug Administration has authorised the use of a third dose of the Pfizer-BioNTech's COVID-19 vaccine for children ages 12 to 15, and reduced the wait time between initial vaccination and an extra dose from six months to five months for all ages.